BACKGROUND: Human papillomavirus type 58 (HPV-58) accounts for a much higher proportion of cervical cancers in East Asia than other types. A classification system of HPV-58, which is essential for molecular epidemiological study, is lacking. METHODS AND RESULTS: This study analyzed the sequences of 401 isolates collected from 15 countries and cities. The 268 unique concatenated E6-E7-E2-E5-L1-LCR sequences that comprised 57% of the whole HPV-58 genome showed 4 distinct clusters. L1 and LCR produced tree topologies that best resembled the concatenated sequences and thus are the most appropriate surrogate regions for lineage classification. Moreover, short fragments from L1 (nucleotides 6014-6539) and LCR (nucleotides 7257-7429 and 7540-52) were found to contain sequence signatures informative for lineage identification. Lineage A was the most prevalent lineage across all regions. Lineage C was more frequent in Africa than elsewhere, whereas lineage D was more prevalent in Africa than in Asia. Among lineage A variants, sublineage A2 dominated in Africa, the Americas, and Europe, but not in Asia. Sublineage A1, which represents the prototype that originated from a patient with cancer, was rare worldwide except in Asia. CONCLUSIONS: HPV-58 can be classified into 4 lineages that show some degree of ethnogeographic predilection in distribution. The evolutionary, epidemiological, and pathological characteristics of these lineages warrant further study.
BACKGROUND:Human papillomavirus type 58 (HPV-58) accounts for a much higher proportion of cervical cancers in East Asia than other types. A classification system of HPV-58, which is essential for molecular epidemiological study, is lacking. METHODS AND RESULTS: This study analyzed the sequences of 401 isolates collected from 15 countries and cities. The 268 unique concatenated E6-E7-E2-E5-L1-LCR sequences that comprised 57% of the whole HPV-58 genome showed 4 distinct clusters. L1 and LCR produced tree topologies that best resembled the concatenated sequences and thus are the most appropriate surrogate regions for lineage classification. Moreover, short fragments from L1 (nucleotides 6014-6539) and LCR (nucleotides 7257-7429 and 7540-52) were found to contain sequence signatures informative for lineage identification. Lineage A was the most prevalent lineage across all regions. Lineage C was more frequent in Africa than elsewhere, whereas lineage D was more prevalent in Africa than in Asia. Among lineage A variants, sublineage A2 dominated in Africa, the Americas, and Europe, but not in Asia. Sublineage A1, which represents the prototype that originated from a patient with cancer, was rare worldwide except in Asia. CONCLUSIONS:HPV-58 can be classified into 4 lineages that show some degree of ethnogeographic predilection in distribution. The evolutionary, epidemiological, and pathological characteristics of these lineages warrant further study.
Authors: Itzel E Calleja-Macias; Luisa L Villa; Jose C Prado; Mina Kalantari; Bruce Allan; Anna-Lise Williamson; Lap-Ping Chung; Robert J Collins; Rosemary E Zuna; S Terence Dunn; Tang-Yuan Chu; Heather A Cubie; Kate Cuschieri; Magnus von Knebel-Doeberitz; Claudia R Martins; Gloria I Sanchez; F Xavier Bosch; Nubia Munoz; Hans-Ulrich Bernard Journal: J Virol Date: 2005-11 Impact factor: 5.103
Authors: Nubia Muñoz; F Xavier Bosch; Xavier Castellsagué; Mireia Díaz; Silvia de Sanjose; Doudja Hammouda; Keerti V Shah; Chris J L M Meijer Journal: Int J Cancer Date: 2004-08-20 Impact factor: 7.396
Authors: L Ho; S Y Chan; R D Burk; B C Das; K Fujinaga; J P Icenogle; T Kahn; N Kiviat; W Lancaster; P Mavromara-Nazos Journal: J Virol Date: 1993-11 Impact factor: 5.103
Authors: Paul K S Chan; Wendy C S Ho; Mei-Yung Yu; Wai-Mei Pong; Alexander C L Chan; Amanda K C Chan; Tak-Hong Cheung; Martin C S Wong; Ka-Fai To; Ho-Keung Ng Journal: Int J Cancer Date: 2009-10-01 Impact factor: 7.396
Authors: Paul K S Chan; Ching-Wan Lam; Tak-Hong Cheung; William W H Li; Keith W K Lo; May Y M Chan; Jo L K Cheung; Augustine F Cheng Journal: J Natl Cancer Inst Date: 2002-08-21 Impact factor: 13.506
Authors: Long Fu Xi; Mark Schiffman; Laura A Koutsky; James P Hughes; Rachel L Winer; Constance Mao; Ayaka Hulbert; Shu-Kuang Lee; Zhenping Shen; Nancy B Kiviat Journal: J Natl Cancer Inst Date: 2014-09-13 Impact factor: 13.506
Authors: Mónica Molano; Oscar Buitrago; Pablo Moreno-Acosta; Suzanne M Garland; Nicolás Morales; Antonio Huertas; Teresa Martinez; Oscar Gamboa; Sepehr N Tabrizi; Alyssa Cornall; Nubia Muñoz Journal: Oncol Lett Date: 2018-06-08 Impact factor: 2.967
Authors: Paul K S Chan; Chuqing Zhang; Jong-Sup Park; Karen K Smith-McCune; Joel M Palefsky; Lucia Giovannelli; Francois Coutlée; Samantha Hibbitts; Ryo Konno; Wannapa Settheetham-Ishida; Tang-Yuan Chu; Annabelle Ferrera; María Alejandra Picconi; Federico De Marco; Yin-Ling Woo; Tainá Raiol; Patricia Piña-Sánchez; Jeong-Hoon Bae; Martin C S Wong; Mike Z Chirenje; Tsitsi Magure; Anna-Barbara Moscicki; Alison N Fiander; Giuseppina Capra; Eun Young Ki; Yi Tan; Zigui Chen; Robert D Burk; Martin C W Chan; Tak-Hong Cheung; David Pim; Lawrence Banks Journal: Int J Cancer Date: 2012-11-29 Impact factor: 7.396
Authors: Ana Pavla Almeida Diniz Gurgel; Bárbara Simas Chagas; Carolina Medeiros do Amaral; Kamylla Conceição Gomes Nascimento; Lígia Rosa Sales Leal; Jacinto da Costa Silva Neto; Maria Tereza Cartaxo Muniz; Antonio Carlos de Freitas Journal: Biomed Res Int Date: 2015-02-22 Impact factor: 3.411
Authors: Zigui Chen; Mark Schiffman; Rolando Herrero; Rob DeSalle; Kathryn Anastos; Michel Segondy; Vikrant V Sahasrabuddhe; Patti E Gravitt; Ann W Hsing; Paul K S Chan; Robert D Burk Journal: Virology Date: 2018-01-11 Impact factor: 3.616
Authors: Paul K S Chan; María Alejandra Picconi; Tak Hong Cheung; Lucia Giovannelli; Jong Sup Park Journal: Crit Rev Clin Lab Sci Date: 2012 Jul-Aug Impact factor: 6.250